Advances in biocompatibility and physico-chemical characterization of microspheres for cell encapsulation

Advanced Drug Delivery Reviews

Volumn 67-68, Issue , 2014, Pages 111-130

  Rokstad, Anne Mari A ^a,d   Lacík, Igor ^b   de Vos, Paul ^c   Strand, Berit L ^a,d  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b POLYMER INSTITUTE   (Slovakia)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d Central Norway Regional Health Authority   (Norway)

Author keywords

Biocompatibility; Biotolerability; Cell encapsulation; Cell therapy; Complement; Host response; Microbeads; Microcapsules; Microspheres; Permeability; Physico chemical characterization

Indexed keywords

BIOCOMPATIBILITY; CELLS; CHARACTERIZATION; DISEASE CONTROL; ENCAPSULATION; MECHANICAL PERMEABILITY; MICROSPHERES;

BIOTOLERABILITY; CELL ENCAPSULATIONS; CELL THERAPY; COMPLEMENT; HOST RESPONSE; MICROBEADS; MICROCAPSULES; PHYSICO-CHEMICAL CHARACTERIZATION;

CYTOLOGY;

MICROSPHERE; PROTEIN;

ANIMAL; CELL TRANSPLANTATION; CHEMICAL PHENOMENA; ELASTICITY; HUMAN; MATERIALS TESTING; METABOLISM; SURFACE PROPERTY;

ANIMALS; CELL TRANSPLANTATION; ELASTICITY; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MATERIALS TESTING; MICROSPHERES; PROTEINS; SURFACE PROPERTIES;

EID: 84898544959     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2013.07.010     Document Type: Review

References (251)

1. Barton F.B., Rickels M.R., Alejandro R., Hering B.J., Wease S., Naziruddin B., Oberholzer J., Odorico J.S., Garfinkel M.R., Levy M., Pattou F., Berney T., Secchi A., Messinger S., Senior P.A., Maffi P., Posselt A., Stock P.G., Kaufman D.B., Luo X., Kandeel F., Cagliero E., Turgeon N.A., Witkowski P., Naji A., O'Connell P.J., Greenbaum C., Kudva Y.C., Brayman K.L., Aull M.J., Larsen C., Kay T.W., Fernandez L.A., Vantyghem M.C., Bellin M., Shapiro A.M. Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care 2012, 35:1436-1445.
2. O'Sullivan E.S., Vegas A., Anderson D.G., Weir G.C. Islets transplanted in immunoisolation devices: a review of the progress and the challenges that remain. Endocr. Rev. 2011, 32:827-844.
3. Lacik I. Current status on immunoprotection of transplanted islets: focus on islet microencapsulation. Micro. Nanosyst. 2013, 5. (000-000).
4. Giraldo J.A., Weaver J.D., Stabler C.L. Tissue engineering approaches to enhancing clinical islet transplantation through tissue engineering strategies. J. Diabetes Sci. Technol. 2010, 4:1238-1247.
5. Zanin M.P., Pettingill L.N., Harvey A.R., Emerich D.F., Thanos C.G., Shepherd R.K. The development of encapsulated cell technologies as therapies for neurological and sensory diseases. J. Control. Release 2012, 160:3-13.
6. Harm S., Strobl K., Hartmann J., Falkenhagen D. Alginate-encapsulated human hepatoma C3A cells for use in a bioartificial liver device-the hybrid-MDS. Int. J. Artif. Organs 2009, 32:769-778.
7. Paul A., Chen G., Khan A., Rao V.T., Shum-Tim D., Prakash S. Genipin-cross-linked microencapsulated human adipose stem cells augment transplant retention resulting in attenuation of chronically infarcted rat heart fibrosis and cardiac dysfunction. Cell Transplant. 2012, 21:2735-2751.
8. Jacobs-Tulleneers-Thevissen M., Chintinne Z.Ling, Gillard P., Schoonjans L., Delvaux G., Strand B., Gorous F., Keymeulen B., Pipeleers D.G. Sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patient. Diabetologia 2013, 56:1605-1614.
9. Calafiore R., Basta G., Luca G., Lemmi A., Montanucci M.P., Calabrese G., Racanicchi L., Mancuso F., Brunetti P. Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases. Diabetes Care 2006, 29:137-138.
10. Tuch B.E., Keogh G.W., Williams L.J., Wu W., Foster J.L., Vaithilingam V., Philips R. Safety and viability of microencapsulated human islets transplanted into diabetic humans. Diabetes Care 2009, 32:1887-1889.
11. (accessed March 21 2013). http://www.lctglobal.com/Products-and-Services/Diabecell/.
12. de Vos P., Bucko M., Gemeiner P., Navratil M., Svitel J., Faas M., Strand B.L., Skjak-Braek G., Morch Y.A., Vikartovska A., Lacik I., Kollarikova G., Orive G., Poncelet D., Pedraz J.L., Ansorge-Schumacher M.B. Multiscale requirements for bioencapsulation in medicine and biotechnology. Biomaterials 2009, 30:2559-2570.
13. Thu B., Bruheim P., Espevik T., Smidsrod O., Soon-Shiong P., Skjak-Braek G. Alginate polycation microcapsules. I. Interaction between alginate and polycation. Biomaterials 1996, 17:1031-1040.
14. de Vos P., Spasojevic M., De Haan B., Faas M.M. The association between in vivo physicochemical changes and inflammatory responses against alginate based microcapsules. Biomaterials 2012, 33:5552-5559.
15. Rokstad A.M., Strand B., Rian K., Steinkjer B., Kulseng B., Skjak-Braek G., Espevik T. Evaluation of different types of alginate microcapsules as bioreactors for producing endostatin. Cell Transplant. 2003, 12:351-364.
16. De Haan B.J., Rossi A., Faas M.M., Smelt M.J., Sonvico F., Colombo P., de Vos P. Structural surface changes and inflammatory responses against alginate-based microcapsules after exposure to human peritoneal fluid. J. Biomed. Mater. Res. 2011, 98:394-403.
17. Rokstad A.M., Brekke O.L., Steinkjer B., Ryan L., Kollarikova G., Strand B.L., Skjak-Braek G., Lacik I., Espevik T., Mollnes T.E. Alginate microbeads are complement compatible, in contrast to polycation containing microcapsules, as revealed in a human whole blood model. Acta Biomater. 2011, 7:2566-2578.
18. Tam S.K., Bilodeau S., Dusseault J., Langlois G., Halle J.P., Yahia L.H. Biocompatibility and physicochemical characteristics of alginate-polycation microcapsules. Acta Biomater. 2011, 7:1683-1692.
19. Halle J.P., de Vos P., Rosenberg L. The Bioartificial Pancreas and Other Biohybrid Therapies 2009, Transworld Research Network, Kerala.
20. Lacik I. Polymer chemistry in diabetes treatment by encapsulated islets of Langerhans: review to 2006. Aust. J. Chem. 2006, 59:508-524.
21. Ratner B.D. The biocompatibility manifesto: biocompatibility for the twenty-first century. J. Cardiovasc. Transl. Res. 2011, 4:523-527.
22. Hilborn J., Bjursten L.M. A new and evolving paradigm for biocompatibility. J. Tissue Eng. Regen. Med. 2007, 1:110-119.
23. Williams D.F. On the mechanisms of biocompatibility. Biomaterials 2008, 29:2941-2953.
24. de Vos P., Van Hoogmoed C.G., van Zanten J., Netter S., Strubbe J.H., Busscher H.J. Long-term biocompatibility, chemistry, and function of microencapsulated pancreatic islets. Biomaterials 2003, 24:305-312.
25. Levin I.W., Bhargava R. Fourier transform infrared vibrational spectroscopic imaging: Integrating microscopy and molecular recognition. Annual Review of Physical Chemistry, Annual Reviews 2005, 429-474. (Palo Alto).
26. Tam S.K., Dusseault J., Polizu S., Menard M., Halle J.P., Yahia L. Physicochemical model of alginate-poly-l-lysine microcapsules defined at the micrometric/nanometric scale using ATR-FTIR XPS, and ToF-SIMS. Biomaterials 2005, 26:6950-6961.
27. Van Hoogmoed C.G., Busscher H.J., de Vos P. Fourier transform infrared spectroscopy studies of alginate-PLL capsules with varying compositions. J. Biomed. Mater. Res. 2003, 67:172-178.
28. Bogner A., Thollet G., Basset D., Jouneau P.H., Gauthier C. Wet STEM: a new development in environmental SEM for imaging nano-objects included in a liquid phase. Ultramicroscopy 2005, 104:290-301.
29. Xiong X.P., Wang Y., Zou W.W., Duan J.J., Chen Y. Preparation and characterization magnetic chitosan microcapsules. J. Chem. 2013, 2013:1-8. (article ID 585613).
30. Allan-Wojtas P., Truelstrup Hansen L., Paulson A.T. Microstructural studies of probiotic bacteria-loaded alginate microcapsules using standard electron microscopy techniques and anhydrous fixation. LWT 2008, 41:101-108.
31. Hoesli C.A., Kiang R.L.J., Mocinecova D., Speck M., Moskova D.J., Donald-Hague C., Lacik I., Kieffer T.J., Piret J.M. Reversal of diabetes by βTC3 cells encapsulated in alginate beads generated by emulsion and internal gelation. J. Biomed. Mater. Res. B 2012, 100:1017-1028.
32. Lekka M., Sainz-Serp D., Kulik A.J., Wandrey C. Hydrogel microspheres: influence of chemical composition on surface morphology, local elastic properties, and bulk mechanical characteristics. Langmuir 2004, 20:9968-9977.
33. Ye C.H., Drachuk I., Calabrese R., Dai H.Q., Kaplan D.L., Tsukruk V.V. Permeability and micromechanical properties of silk ionomer microcapsules. Langmuir 2012, 28:12235-12244.
34. Xu K.Y., Hercules D.M., Lacik I., Wang T.G. Atomic force microscopy used for the surface characterization of microcapsule immunoisolation devices. J. Biomed. Mater. Res. 1998, 41:461-467.
35. 2+ on alginate microbeads. Biomacromolecules 2006, 7:1471-1480.
36. Vogler E.A. Protein adsorption in three dimensions. Biomaterials 2012, 33:1201-1237.
37. Tam S.K., Dusseault J., Bilodeau S., Langlois G., Halle J.P., Yahia L. Factors influencing alginate gel biocompatibility. J. Biomed. Mater. Res. A 2011, 98A:40-52.
38. Xie H.G., Li X.X., Lv G.J., Xie W.Y., Zhu J., Luxbacher T., Ma R., Ma X.J. Effect of surface wettability and charge on protein adsorption onto implantable alginate-chitosan-alginate microcapsule surfaces. J. Biomed. Mater. Res. A 2010, 92:1357-1365.
39. You J.O., Park S.B., Park H.Y., Haam S., Chung C.H., Kim W.S. Preparation of regular sized Ca-alginate microspheres using membrane emulsification method. J. Microencapsul. 2001, 18:521-532.
40. Hook A.L., Anderson D.G., Langer R., Williams P., Davies M.C., Alexander M.R. High throughput methods applied in biomaterial development and discovery. Biomaterials 2010, 31:187-198.
41. Robitaille R., Halle J.P. Characterization and evaluation of the properties and functions of the microcapsules. THE BIOARTIFICIAL PANCREAS and Other Biohybrid Therapies 2009, 67-85. Transworld Research Network, Kerala. J.P. Halle, P. De Vos, L. Rosenberg (Eds.).
42. Schmidt J.J., Rowley J., Kong H.J. Hydrogels used for cell-based drug delivery. J. Biomed. Mater. Res. A 2008, 87:1113-1122.
43. Thu B., Bruheim P., Espevik T., Smidsrod O., Soon-Shiong P., Skjak-Braek G. Alginate polycation microcapsules. II. Some functional properties. Biomaterials 1996, 17:1069-1079.
44. Van Raamsdonk J.M., Chang P.L. Osmotic pressure test: a simple, quantitative method to assess the mechanical stability of alginate microcapsules. J. Biomed. Mater. Res. 2001, 54:264-271.
45. Kerby A., Jones E.S., Jones P.M., King A.J. Co-transplantation of islets with mesenchymal stem cells in microcapsules demonstrates graft outcome can be improved in an isolated-graft model of islet transplantation in mice. Cytotherapy 2013, 15:192-200.
46. O'Sullivan E.S., Johnson A.S., Omer A., Hollister-Lock J., Bonner-Weir S., Colton C.K., Weir G.C. Rat islet cell aggregates are superior to islets for transplantation in microcapsules. Diabetologia 2010, 53:937-945.
47. 2+ microbeads: in vitro and in vivo function. Artif. Cells Blood Substit. Immobil. Biotechnol. 2008, 36:403-420.
48. Vaithilingam V., Kollarikova G., Qi M.R.G., Lacik I., Oberholzer J., Guillemin G.J., Tuch B.E. Effect of prolonged gelling time on the intrinsic properties of barium alginate microcapsules and its biocompatibility. J. Microencapsul. 2011, 28:499-507.
49. Morch Y.A., Qi M., Gundersen P.O., Formo K., Lacik I., Skjak-Braek G., Oberholzer J., Strand B.L. Binding and leakage of barium in alginate microbeads. J. Biomed. Mater. Res. A 2012, 100:2939-2947.
50. Morch Y.A., Donati I., Strand B.L., Skjak-Braek G. Molecular engineering as an approach to design new functional properties of alginate. Biomacromolecules 2007, 8:2809-2814.
51. Trouche E., Fullana S.G., Mias C., Ceccaldi C., Tortosa F., Seguelas M.H., Calise D., Parini A., Cussac D., Sallerin B. Evaluation of alginate microspheres for mesenchymal stem cell engraftment on solid organ. Cell Transplant. 2010, 19:1623-1633.
52. Hillberg A.L., Kathirgamanathan K., Lam J.B.B., Law L.Y., Garkavenko O., Elliott R.B. Improving alginate-poly-l-ornithine-alginate capsule biocompatibility through genipin crosslinking. J. Biomed. Mater. Res. B 2013, 101:258-268.
53. Mahou R., Wandrey C. Alginate-poly(ethylene glycol) hybrid microspheres with adjustable physical properties. Macromolecules 2010, 43:1371-1378.
54. De Castro M., Orive G., Hernandez R.M., Bartkowiak A., Brylak W., Pedraz J.L. Biocompatibility and in vivo evaluation of oligochitosans as cationic modifiers of alginate/Ca microcapsules. J. Biomed. Mater. Res. 2009, 91:1119-1130.
55. Loh Q.L., Wong Y.Y., Choong C. Combinatorial effect of different alginate compositions, polycations, and gelling ions on microcapsule properties. Colloid Polym. Sci. 2012, 290:619-629.
56. Wong Y.Y., Yuan S.J., Choong C. Degradation of PEG and non-PEG alginate-chitosan microcapsules in different pH environments. Polym. Degrad. Stab. 2011, 96:2189-2197.
57. Bando K., Ohba K., Oiso Y. Deformation analysis of microcapsules compressed by two rigid parallel plates. J. biorheol. 2013, in press. 10.1007/s12573-012-0053-8.
58. Darrabie M.D., Kendall W.F., Opara E.C. Characteristics of poly-l-ornithine-coated alginate microcapsules. Biomaterials 2005, 26:6846-6852.
59. Ma Y., Zhang Y., Zhao S., Wang Y., Wang S., Zhou Y., Li N., Xie H., Yu W., Liu Y., Wang W., Ma X. Modeling and optimization of membrane preparation conditions of the alginate-based microcapsules with response surface methodology. J. Biomed. Mater. Res. A 2012, 100:989-998.
60. Leblond F.A., Tessier J., Halle J.P. Quantitative method for the evaluation of biomicrocapsule resistance to mechanical stress. Biomaterials 1996, 17:2097-2102.
61. Ma Y., Zhang Y., Wang Y., Wang Q., Tan M., Liu Y., Chen L., Li N., Yu W., Ma X. Study of the effect of membrane thickness on microcapsule strength, permeability, and cell proliferation. J. Biomed. Mater. Res. A 2013, 101:1007-1015.
62. Arifin D.R., Manek S., Call E., Arepally A., Bulte J.W.M. Microcapsules with intrinsic barium radiopacity for immunoprotection and X-ray/CT imaging of pancreatic islet cells. Biomaterials 2012, 33:4681-4689.
63. Mazumder M.A.J., Burke N.A.D., Shen F., Potter M.A., Stover H.D.H. Core-cross-linked alginate microcapsules for cell encapsulation. Biomacromolecules 2009, 10:1365-1373.
64. Shen F., Mazumder M.A.J., Burke N.A.D., Stover H.D.H., Potter M.A. Mechanically enhanced microcapsules for cellular gene therapy. J. Biomed. Mater. Res. B 2009, 90:350-361.
65. Luna S.M., Gomes M.E., Mano J.F., Reis R.L. Development of a novel cell encapsulation system based on natural origin polymers for tissue engineering applications. J. Bioact. Compat. Polym. 2010, 25:341-359.
66. Gattas-Asfura K.M., Fraker C.A., Stabler C.L. Covalent stabilization of alginate hydrogel beads via Staudinger ligation: assessment of poly(ethylene glycol) and alginate cross-linkers. J. Biomed. Mater. Res. A 2011, 99:47-57.
67. Hall K.K., Gattas-Asfura K.M., Stabler C.L. Microencapsulation of islets within alginate/poly(ethylene glycol) gels cross-linked via Staudinger ligation. Acta Biomater. 2011, 7:614-624.
68. 2+. Xenotransplantation 2012, 19:355-364.
69. Thanos C.G., Calafiore R., Basta G., Bintz B.E., Bell W.J., Hudak J., Vasconcellos A., Schneider P., Skinner S.J.M., Geaney M., Tan P., Elliot R.B., Tatnell M., Escobar L., Qian H., Mathiowitz E., Emerich D.F. Formulating the alginate-polyornithine biocapsule for prolonged stability: evaluation of composition and manufacturing technique. J. Biomed. Mater. Res. A 2007, 83:216-224.
70. Qi M., Lacik I., Kollarikova G., Strand B.L., Formo K., Wang Y., Marchese E., Mendoza-Elias J.E., Kinzer K.P., Gatti F., Paushter D., Patel S., Oberholzer J. A recommended laparoscopic procedure for implantation of microcapsules in the peritoneal cavity of non-human primates. J. Surg. Res. 2011, 168:e117-e123.
71. Mercade-Prieto R., Zhang Z.B. Mechanical characterization of microspheres-capsules, cells and beads: a review. J. Microencapsul. 2012, 29:277-285.
72. Mercade-Prieto R., Allen R., Zhang Z.B., York D., Preece J.A., Goodwin T.E. Failure of elastic-plastic core-shell microcapsules under compression. AICHE J. 2012, 58:2674-2681.
73. Schuldt U., Hunkeler D. Characterization methods for microcapsules. Minerva Biotecnol. 2000, 12:249-264.
74. Uludag H., De Vos P., Tresco P.A. Technology of mammalian cell encapsulation. Adv. Drug Deliv. Rev. 2000, 42:29-64.
75. Gray D.W. An overview of the immune system with specific reference to membrane encapsulation and islet transplantation. Ann. N. Y. Acad. Sci. 2001, 944:226-239.
76. Brissova M., Petro M., Lacik I., Powers A.C., Wang T. Evaluation of microcapsule permeability via inverse size exclusion chromatography. Anal. Biochem. 1996, 242:104-111.
77. Trivedi N., Steil G.M., Colton C.K., Bonner-Weir S., Weir G.C. Improved vascularization of planar membrane diffusion devices following continuous infusion of vascular endothelial growth factor. Cell Transplant. 2000, 9:115-124.
78. Desai T.A., West T., Cohen M., Boiarski T., Rampersaud A. Nanoporous microsystems for islet cell replacement. Adv. Drug Deliv. Rev. 2004, 56:1661-1673.
79. Kobayashi T., Aomatsu Y., Iwata H., Kin T., Kanehiro H., Hisanaga M., Ko S., Nagao M., Nakajima Y. Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression. Transplantation 2003, 75:619-625.
80. Lanza R.P., Kuhtreiber W.M., Ecker D., Staruk J.E., Chick W.L. Xenotransplantation of porcine and bovine islets without immunosuppression using uncoated alginate microspheres. Transplantation 1995, 59:1377-1384.
81. Dugas V., Beauchamp C., Halle J.P., Lesage S. Protection by microencapsulation from antigen recognition, immune cells, antibodies, and complement components. The Bioartificial Pancreas and Other Biohybrid Therapies 2009, 261-277. Transworld Research Network, Kerala. J.P. Halle, P. De Vos, L. Rosenberg (Eds.).
82. Lin C.C., Boyer P.D., Aimetti A.A., Anseth K.S. Regulating MCP-1 diffusion in affinity hydrogels for enhancing immuno-isolation. J. Control. Release 2010, 142:384-391.
83. Su J., Hu B.H., Lowe W.L., Kaufman D.B., Messersmith P.B. Anti-inflammatory peptide-functionalized hydrogels for insulin-secreting cell encapsulation. Biomaterials 2010, 31:308-314.
84. Park S.J., Shin S., Koo O.J., Moon J.H., Jang G., Ahn C., Lee B.C., Yoo Y.J. Functional improvement of porcine neonatal pancreatic cell clusters via conformal encapsulation using an air-driven encapsulator. Exp. Mol. Med. 2012, 44:20-25.
85. Lv G.J., Sun Z.J., Li S.Y., Yu W.T., Xie Y.B., Zhang Y., Xie H.G., Li X.X., Wang W., Ma X.J. Permeability changes of the cell-contained microcapsules visualized by confocal laser scanning microscope. J. Biomed. Mater. Res. A 2009, 90:773-783.
86. Wikstrom J., Elomaa M., Syvajarvi H., Kuokkanen J., Yliperttula M., Honkakoski P., Urtti A. Alginate-based microencapsulation of retinal pigment epithelial cell line for cell therapy. Biomaterials 2008, 29:869-876.
87. Robitaille R., Leblond F.A., Bourgeois Y., Henley N., Loignon M., Halle J.P. Studies on small (<350microm) alginate-poly-l-lysine microcapsules. V. Determination of carbohydrate and protein permeation through microcapsules by reverse-size exclusion chromatography. J. Biomed. Mater. Res. 2000, 50:420-427.
88. Dusseault J., Leblond F.A., Robitaille R., Jourdan G., Tessier J., Menard M., Henley N., Halle J.P. Microencapsulation of living cells in semi-permeable membranes with covalently cross-linked layers. Biomaterials 2005, 26:1515-1522.
89. Sun Y.M., Liang X.F., Zhu M.J., Zhao J.G., Cheng Y.S., Duan Y.R. Characterization and bioactivity of alginate-quaternized chitosan microcapsules. J. Macromol. Sci. A 2012, 49:483-489.
90. Ranganath S.H., Tan A.L., He F., Wang C.H., Krantz W.B. Control and enhancement of permselectivity of membrane-based microcapsules for favorable biomolecular transport and immunoisolation. AICHE J. 2011, 57:3052-3062.
91. Yu W.T., Song H.Y., Zheng G.S., Liu X.D., Zhang Y., Ma X.J. Study on membrane characteristics of alginate-chitosan microcapsule with cell growth. J. Membr. Sci. 2011, 377:214-220.
92. Brissova M., Lacik I., Powers A.C., Anilkumar A.V., Wang T. Control and measurement of permeability for design of microcapsule cell delivery system. J. Biomed. Mater. Res. 1998, 39:61-70.
93. Gattas-Asfura K.M., Fraker C.A., Stabler C.L. Perfluorinated alginate for cellular encapsulation. J Biomed. Mater. Res. 2012, 100:1963-1971.
94. Khanna O., Moya M.L., Opara E.C., Brey E.M. Synthesis of multilayered alginate microcapsules for the sustained release of fibroblast growth factor-1. J. Biomed. Mater. Res. A 2010, 95:632-640.
95. Lacik I., Chorvat D.J. Visualisation techniques in the characterization of polymer microcapsules: confocal laser scanning microscopy and atomic force microscopy. The Bioartificial Pancreas and Other Biohybrid Therapies 2009, 137-175. Transworld Research Network, Kerala. J.P. Halle, P. De Vos, L. Rosenberg (Eds.).
96. Pawley J.B. Handbook of Biological Confocal Microscopy 2006, Springer-Verlag New York Inc.
97. Jenkins M.C., Egelhaaf S.U. Confocal microscopy of colloidal particles: towards reliable, optimum coordinates. Adv. Colloid Interf. Sci. 2008, 136:65-92.
98. Pygall S.R., Whetstone J., Timmins P., Melia C.D. Pharmaceutical applications of confocal laser scanning microscopy: the physical characterisation of pharmaceutical systems. Adv. Drug Deliv. Rev. 2007, 59:1434-1452.
99. Vandenbossche G.M.R., Van Oosveldt P., Demeester J., Remon J.-P. The molecular weight cut-off of microcapsules is determined by the reaction between alginate and polylysine. Biotechnol. Bioeng. 1993, 42:381-386.
100. Lamprecht A., Schafer U., Lehr C.M. Structural analysis of microparticles by confocal laser scanning microscopy. AAPS PharmSciTech 2000, 1:10-19.
101. Lamprecht A., Schafer U.F., Lehr C.M. Characterization of microcapsules by confocal laser scanning microscopy: structure, capsule wall composition and encapsulation rate. Eur. J. Pharm. Biopharm. 2000, 49:1-9.
102. Lamprecht A., Schafer U.F., Lehr C.M. Visualization and quantification of polymer distribution in microcapsules by confocal laser scanning microscopy (CLSM). Int. J. Pharm. 2000, 196:223-226.
103. Strand B.L., Morch Y.A., Espevik T., Skjak-Braek G. Visualization of alginate-poly-l-lysine-alginate microcapsules by confocal laser scanning microscopy. Biotechnol. Bioeng. 2003, 82:386-394.
104. Wolf R., Zimmermann D., Weber P., Feilen P., Ehrhart F., Jungjohann M.S., Katsen A., Behringer P., Gessner P., Pliess L., Steinbach A., Spitz J., Vasquez J.A., Schneider S., Bamberg E., Weber M.M., Zimmermann U., Zimmermann H. Real-time 3-D dark-field microscopy for the validation of the cross-linking process of alginate microcapsules. Biomaterials 2005, 26:6386-6393.
105. Zimmermann H., Hillgartner M., Manz B., Feilen P., Brunnenmeier F., Leinfelder U., Weber M., Cramer H., Schneider S., Hendrich C., Volke F., Zimmermann U. Fabrication of homogeneously cross-linked, functional alginate microcapsules validated by NMR-CLSM- and AFM-imaging. Biomaterials 2003, 24:2083-2096.
106. Podskocova J., Chorvat D., Kollarikova G., Lacik I. Characterization of polyelectrolyte microcapsules by confocal laser scanning microscopy and atomic force microscopy. Laser Phys. 2005, 15:545-551.
107. Leung A., Ramaswamy Y., Munro P., Lawrie G., Nielsen L., Trau M. Emulsion strategies in the microencapsulation of cells: pathways to thin coherent membranes. Biotechnol. Bioeng. 2005, 92:45-53.
108. Chen H., Ouyang W., Lawuyi B., Martoni C., Prakash S. Reaction of chitosan with genipin and its fluorogenic attributes for potential microcapsule membrane characterization. J. Biomed. Mater. Res. A 2005, 75:917-927.
109. Jung Y.S., Jeong J.H., Yook S., Im B.H., Seo J., Hong S.W., Park J.B., Yan V.C., Lee D.Y., Byun Y. Surface modification of pancreatic islets using heparin-DOPA conjugate and anti-CD154 mAb for the prolonged survival of intrahepatic transplanted islets in a xenograft model. Biomaterials 2012, 33:295-303.
110. Kizilel S., Scavone A., Liu X.A., Nothias J.M., Ostrega D., Witkowski P., Millis M. Encapsulation of pancreatic islets within nano-thin functional polyethylene glycol coatings for enhanced insulin secretion. Tissue Eng. A 2010, 16:2217-2228.
111. Teramura Y., Kaneda Y., Iwata H. Islet-encapsulation in ultra-thin layer-by-layer membranes of poly(vinyl alcohol) anchored to poly(ethylene glycol)-lipids in the cell membrane. Biomaterials 2007, 28:4818-4825.
112. Teramura Y., Oommen O.P., Olerud J., Hilborn J., Nilsson B. Microencapsulation of cells, including islets, within stable ultra-thin membranes. Biomaterials 2013, 34:2683-2693.
113. Jeong J.H., Yook S., Hwang J.W., Jung M.J., Moon H.T., Lee D.Y., Byun Y. Synergistic effect of surface modification with poly(ethylene glycol) and immunosuppressants on repetitive pancreatic islet transplantation into antecedently sensitized rat. Transplant. Proc. 2013, 45:585-590.
114. Lee D.Y., Byun Y. Pancreatic islet PEGylation as an immunological polymeric restraint. Biotechnol. Bioprocess Eng. 2010, 15:76-85.
115. Aikawa T., Konno T., Takai M., Ishihara K. Spherical phospholipid polymer hydrogels for cell encapsulation prepared with a flow-focusing microfluidic channel device. Langmuir 2012, 28:2145-2150.
116. Gardner C.M., Burke N.A.D., Chu T., Shen F., Potter M.A., Stover H.D.H. Poly(methyl vinyl ether-alt-maleic acid) polymers for cell encapsulation. J. Biomater. Sci. Polym. Ed. 2011, 22:2127-2145.
117. Luan N.M., Iwata H. Xenotransplantation of islets enclosed in agarose microcapsule carrying soluble complement receptor 1. Biomaterials 2012, 33:8075-8081.
118. Kozlovskaya V., Zavgorodnya O., Chen Y., Ellis K., Tse H.M., Cui W.X., Thompson J.A., Kharlampieva E. Ultrathin polymeric coatings based on hydrogen-bonded polyphenol for protection of pancreatic islet cells. Adv. Funct. Mater. 2012, 22:3389-3398.
119. Teramura Y., Iwata H. Bioartificial pancreas: microencapsulation and conformal coating of islet of Langerhans. Adv. Drug Deliv. Rev. 2010, 62:827-840.
120. Luan N.M., Teramura Y., Iwata H. Immobilization of the soluble domain of human complement receptor 1 on agarose-encapsulated islets for the prevention of complement activation. Biomaterials 2010, 31:8847-8853.
121. Teramura Y., Lwata H. Islet encapsulation with living cells for improvement of biocompatibility. Biomaterials 2009, 30:2270-2275.
122. Stokke B.T., Smidsrod O., Zanetti F., Strand W., Skjak-Bræk G. Distribution of uronate residues in alginate chains in relation to alginate gelling properties. 2. Enrichment of β-D-mannuronic acid and depletion of α-l-guluronic acid in sol fraction. Carbohydr. Polym. 1993, 21:39-46.
123. Flo T.H., Ryan L., Latz E., Takeuchi O., Monks B.G., Lien E., Halaas O., Akira S., Skjak-Bræk G., Golenbock D.T., Espevik T. Involvement of toll-like receptor(TLR)2 and TLR4 in cell activation by mannuronic acid polymers. J. Biol. Chem. 2002, 277:35489-35495.
124. Otterlei M., Ostgaard K., Skjak-Braek G., Smidsrod O., Soon-Shiong P., Espevik T. Induction of cytokine production from human monocytes stimulated with alginate. J. Immunother. 1991, 10:286-291.
125. Alshamkhani A., Duncan R. Radioiodination of alginate via covalently-bound tyrosinamide allows monitoring of its fate in-vivo. J. Bioact. Compat. Polym. 1995, 10:4-13.
126. Anderson J.M. Inflammatory response to implants. ASAIO Trans. 1988, 34:101-107.
127. Anderson J.M., Rodriguez A., Chang D.T. Foreign body reaction to biomaterials. Semin. Immunol. 2008, 20:86-100.
128. Nilsson B., Korsgren O., Lambris J.D., Ekdahl K.N. Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition?. Trends Immunol. 2010, 31:32-38.
129. Franz S., Rammelt S., Scharnweber D., Simon J.C. Immune responses to implants-a review of the implications for the design of immunomodulatory biomaterials. Biomaterials 2011, 32:6692-6709.
130. Rihova B. Immunocompatibility and biocompatibility of cell delivery systems. Adv. Drug Deliv. Rev. 2000, 42:65-80.
131. Van Raamsdonk J.M., Cornelius R.M., Brash J.L., Chang P.L. Deterioration of polyamino acid-coated alginate microcapsules in vivo. J. Biomater. Sci. Polym. Ed. 2002, 13:863-884.
132. Tam S.K., De Haan B.J., Faas M.M., Halle J.P., Yahia L., de Vos P. Adsorption of human immunoglobulin to implantable alginate-poly-l-lysine microcapsules: effect of microcapsule composition. J. Biomed. Mater. Res. A 2009, 89:609-615.
133. Robitaille R., Dusseault J., Henley N., Desbiens K., Labrecque N., Halle J.P. Inflammatory response to peritoneal implantation of alginate-poly-l-lysine microcapsules. Biomaterials 2005, 26:4119-4127.
134. de Vos P., Van Hoogmoed C.G., De Haan B.J., Busscher H.J. Tissue responses against immunoisolating alginate-PLL capsules in the immediate posttransplant period. J. Biomed. Mater. Res. 2002, 62:430-437.
135. Bunger C.M., Gerlach C., Freier T., Schmitz K.P., Pilz M., Werner C., Jonas L., Schareck W., Hopt U.T., de Vos P. Biocompatibility and surface structure of chemically modified immunoisolating alginate-PLL capsules. J. Biomed. Mater. Res. A 2003, 67:1219-1227.
136. Babensee J.E., Cornelius R.M., Brash J.L., Sefton M.V. Immunoblot analysis of proteins associated with HEMA-MMA microcapsules: human serum proteins in vitro and rat proteins following implantation. Biomaterials 1998, 19:839-849.
137. Safley S.A., Cui H., Cauffiel S., Tucker-Burden C., Weber C.J. Biocompatibility and immune acceptance of adult porcine islets transplanted intraperitoneally in diabetic NOD mice in calcium alginate poly-l-lysine microcapsules versus barium alginate microcapsules without poly-l-lysine. J. Diabetes Sci. Technol. 2008, 2:760-767.
138. Dufrane D., Goebbels R.M., Saliez A., Guiot Y., Gianello P. Six-month survival of microencapsulated pig islets and alginate biocompatibility in primates: proof of concept. Transplantation 2006, 81:1345-1353.
139. Elliott R.B., Escobar L., Calafiore R., Basta G., Garkavenko O., Vasconcellos A., Bambra C. Transplantation of micro- and macroencapsulated piglet islets into mice and monkeys. Transplant. Proc. 2005, 37:466-469.
140. Bonomini M., Pavone B., Sirolli V., Del Buono F., Di Cesare M., Del Boccio P., Amoroso L., Di Ilio C., Sacchetta P., Federici G., Urbani A. Proteomics characterization of protein adsorption onto hemodialysis membranes. J. Proteome Res. 2006, 5:2666-2674.
141. Urbani A., Sirolli V., Lupisella S., Levi-Mortera S., Pavone B., Pieroni L., Amoroso L., Di V.R., Bucci S., Bernardini S., Sacchetta P., Bonomini M. Proteomic investigations on the effect of different membrane materials on blood protein adsorption during haemodialysis. Blood Transfus. 2012, 10(Suppl. 2):s101-s112.
142. Roach P., Farrar D., Perry C.C. Interpretation of protein adsorption: surface-induced conformational changes. J. Am. Chem. Soc. 2005, 127:8168-8173.
143. Sethuraman A., Han M., Kane R.S., Belfort G. Effect of surface wettability on the adhesion of proteins. Langmuir 2004, 20:7779-7788.
144. Wettero J., Askendal A., Bengtsson T., Tengvall P. On the binding of complement to solid artificial surfaces in vitro. Biomaterials 2002, 23:981-991.
145. Arima Y., Kawagoe M., Toda M., Iwata H. Complement activation by polymers carrying hydroxyl groups. ACS Appl. Mater. Interfaces 2009, 1:2400-2407.
146. Toda M., Kitazawa T., Hirata I., Hirano Y., Iwata H. Complement activation on surfaces carrying amino groups. Biomaterials 2008, 29:407-417.
147. Toda M., Arima Y., Iwata H. Complement activation on degraded polyethylene glycol-covered surface. Acta Biomater. 2010, 6:2642-2649.
148. Engberg A.E., Rosengren-Holmberg J.P., Chen H., Nilsson B., Lambris J.D., Nicholls I.A., Ekdahl K.N. Blood protein-polymer adsorption: implications for understanding complement-mediated hemoincompatibility. J. Biomed. Mater. Res. A 2011, 97:74-84.
149. Ferraz N., Nilsson B., Hong J., Karlsson O.M. Nanopore size affects complement activation. J. Biomed. Mater. Res. A 2008, 87:575-581.
150. Gros P., Milder F.J., Janssen B.J. Complement driven by conformational changes. Nat. Rev. Immunol. 2008, 8:48-58.
151. Wettero J., Bengtsson T., Tengvall P. Complement activation on immunoglobulin G-coated hydrophobic surfaces enhances the release of oxygen radicals from neutrophils through an actin-dependent mechanism. J. Biomed. Mater. Res. 2000, 51:742-751.
152. Wettero J., Bengtsson T., Tengvall P. C1q-independent activation of neutrophils by immunoglobulin M-coated surfaces. J. Biomed. Mater. Res. 2001, 57:550-558.
153. Andersson J., Ekdahl K.N., Lambris J.D., Nilsson B. Binding of C3 fragments on top of adsorbed plasma proteins during complement activation on a model biomaterial surface. Biomaterials 2005, 26:1477-1485.
154. Tang L., Eaton J.W. Fibrin(ogen) mediates acute inflammatory responses to biomaterials. J. Exp. Med. 1993, 178:2147-2156.
155. Tang L., Ugarova T.P., Plow E.F., Eaton J.W. Molecular determinants of acute inflammatory responses to biomaterials. J. Clin. Invest. 1996, 97:1329-1334.
156. Xu L.C., Siedlecki C.A. Atomic force microscopy studies of the initial interactions between fibrinogen and surfaces. Langmuir 2009, 25:3675-3681.
157. Xu L.C., Siedlecki C.A. Effects of surface wettability and contact time on protein adhesion to biomaterial surfaces. Biomaterials 2007, 28:3273-3283.
158. Zheng J.N., Xie H.G., Yu W.T., Liu X.D., Xie W.Y., Zhu J., Ma X.J. Chitosan-g-MPEG-modified alginate/chitosan hydrogel microcapsules: a quantitative study of the effect of polymer architecture on the resistance to protein adsorption. Langmuir 2010, 26:17156-17164.
159. Rokstad A.M., Brekke O.L., Steinkjer B., Ryan L., Kollarikova G., Strand B.L., Skjak-Braek G., Lambris J.D., Lacik I., Mollnes T.E., Espevik T. The induction of cytokines by polycation containing microspheres by a complement dependent mechanism. Biomaterials 2013, 34:621-630.
160. Smith A.M., Hunt N.C., Shelton R.M., Birdi G., Grover L.M. Alginate hydrogel has a negative impact on in vitro collagen 1 deposition by fibroblasts. Biomacromolecules 2012, 13:4032-4038.
161. Mercer P.F., Chambers R.C. Coagulation and coagulation signalling in fibrosis. Biochim. Biophys. Acta 2013, 1832:1018-1027.
162. Tang L., Liu L., Elwing H.B. Complement activation and inflammation triggered by model biomaterial surfaces. J. Biomed. Mater. Res. 1998, 41:333-340.
163. Akalin H.E., Fisher K.A., Laleli Y., Caglar S. Bactericidal activity of ascitic fluid in patients with nephrotic syndrome. Eur. J. Clin. Invest. 1985, 15:138-140.
164. Pattrick M., Luckett J., Yue L., Stover C. Dual role of complement in adipose tissue. Mol. Immunol. 2009, 46:755-760.
165. Reis E.S., Barbuto J.A., Isaac L. Complement components, regulators and receptors are produced by human monocyte-derived dendritic cells. Immunobiology 2007, 212:151-157.
166. Vincent F., de la Salle H., Bohbot A., Bergerat J.P., Hauptmann G., Oberling F. Synthesis and regulation of complement components by human monocytes/macrophages and by acute monocytic leukemia. DNA Cell Biol. 1993, 12:415-423.
167. Ricklin D., Hajishengallis G., Yang K., Lambris J.D. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 2010, 11:785-797.
168. O'Brien M. The reciprocal relationship between inflammation and coagulation. Top. Co. Anim. Med. 2012, 27:46-52.
169. Markiewski M.M., Nilsson B., Ekdahl K.N., Mollnes T.E., Lambris J.D. Complement and coagulation: strangers or partners in crime?. Trends Immunol. 2007, 28:184-192.
170. Syrovets T., Lunov O., Simmet T. Plasmin as a proinflammatory cell activator. J. Leukoc. Biol. 2012, 92:509-519.
171. Amara U., Rittirsch D., Flierl M., Bruckner U., Klos A., Gebhard F., Lambris J.D., Huber-Lang M. Interaction between the coagulation and complement system. Adv. Exp. Med. Biol. 2008, 632:71-79.
172. Amara U., Flierl M.A., Rittirsch D., Klos A., Chen H., Acker B., Bruckner U.B., Nilsson B., Gebhard F., Lambris J.D., Huber-Lang M. Molecular intercommunication between the complement and coagulation systems. J. Immunol. 2010, 185:5628-5636.
173. Huber-Lang M., Sarma J.V., Zetoune F.S., Rittirsch D., Neff T.A., McGuire S.R., Lambris J.D., Warner R.L., Flierl M.A., Hoesel L.M., Gebhard F., Younger J.G., Drouin S.M., Wetsel R.A., Ward P.A. Generation of C5a in the absence of C3: a new complement activation pathway. Nat. Med. 2006, 12:682-687.
174. Oikonomopoulou K., Ricklin D., Ward P.A., Lambris J.D. Interactions between coagulation and complement-their role in inflammation. Semin. Immunopathol. 2012, 34:151-165.
175. Harboe M., Mollnes T.E. The alternative complement pathway revisited. J. Cell Mol. Med. 2008, 12:1074-1084.
176. Bexborn F., Andersson P.O., Chen H., Nilsson B., Ekdahl K.N. The tick-over theory revisited: formation and regulation of the soluble alternative complement C3 convertase (C3(H2O)Bb). Mol. Immunol. 2008, 45:2370-2379.
177. Ricklin D. Manipulating the mediator: modulation of the alternative complement pathway C3 convertase in health, disease and therapy. Immunobiology 2012, 217:1057-1066.
178. Guo R.F., Ward P.A. Role of C5a in inflammatory responses. Annu. Rev. Immunol. 2005, 23:821-852.
179. Osterud B., Bjorklid E. Sources of tissue factor. Semin. Thromb. Hemost. 2006, 32:11-23.
180. Osterud B. Tissue factor expression in blood cells. Thromb. Res. 2010, 125(Suppl. 1):S31-S34.
181. Mollnes T.E., Brekke O.L., Fung M., Fure H., Christiansen D., Bergseth G., Videm V., Lappegard K.T., Kohl J., Lambris J.D. Essential role of the C5a receptor in E. coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood 2002, 100:1869-1877.
182. Rokstad A.M., Strand B., Espevik T., Mollnes T.E. Biocompatibility and biotolerability assessment of microspheres using a whole blood model. Micro. Nanosyst. 2013, 5. (000-000).
183. Brekke O.L., Waage C., Christiansen D., Fure H., Qu H., Lambris J.D., Osterud B., Nielsen E.W., Mollnes T.E. The effects of selective complement and cd14 inhibition on the E. coli-induced tissue factor mRNA upregulation, monocyte tissue factor expression, and tissue factor functional activity in human whole blood. Adv. Exp. Med. Biol. 2013, 734:123-136.
184. Brekke O.L., Christiansen D., Fure H., Fung M., Mollnes T.E. The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood. J. Leukoc. Biol. 2007, 81:1404-1413.
185. Christiansen D., Brekke O.L., Stenvik J., Lambris J.D., Espevik T., Mollnes T.E. Differential effect of inhibiting MD-2 and CD14 on LPS- versus whole E. coli bacteria-induced cytokine responses in human blood. Adv. Exp. Med. Biol. 2012, 946:237-251.
186. Mollnes T.E., Christiansen D., Brekke O.L., Espevik T. Hypothesis: combined inhibition of complement and CD14 as treatment regimen to attenuate the inflammatory response. Adv. Exp. Med. Biol. 2008, 632:253-263.
187. Lappegard K.T., Christiansen D., Pharo A., Thorgersen E.B., Hellerud B.C., Lindstad J., Nielsen E.W., Bergseth G., Fadnes D., Abrahamsen T.G., Hoiby E.A., Schejbel L., Garred P., Lambris J.D., Harboe M., Mollnes T.E. Human genetic deficiencies reveal the roles of complement in the inflammatory network: lessons from nature. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:15861-15866.
188. Lappegard K.T., Riesenfeld J., Brekke O.L., Bergseth G., Lambris J.D., Mollnes T.E. Differential effect of heparin coating and complement inhibition on artificial surface-induced eicosanoid production. Ann. Thorac. Surg. 2005, 79:917-923.
189. Lappegard K.T., Bergseth G., Riesenfeld J., Sexton J., Mollnes T.E. Role of granulocytes and monocytes in the polyvinyl chloride-induced synthesis of interleukin 8, monocyte chemoattractant protein 1, and leukotriene B4. J. Biomed. Mater. Res. A 2005, 74:230-236.
190. Lappegard K.T., Bergseth G., Riesenfeld J., Pharo A., Magotti P., Lambris J.D., Mollnes T.E. The artificial surface-induced whole blood inflammatory reaction revealed by increases in a series of chemokines and growth factors is largely complement dependent. J. Biomed. Mater. Res. A 2008, 87:129-135.
191. Sokolov A., Hellerud B.C., Pharo A., Johannessen E.A., Mollnes T.E. Complement activation by candidate biomaterials of an implantable microfabricated medical device. J. Biomed. Mater. Res. B Appl. Biomater. 2011, 98:323-329.
192. Sokolov A., Hellerud B.C., Johannessen E.A., Mollnes T.E. Inflammatory response induced by candidate biomaterials of an implantable microfabricated sensor. J. Biomed. Mater. Res. A 2012, 100:1142-1150.
193. Smetana K., Vacik J., Souckova D., Krcova Z., Sulc J. The influence of hydrogel functional groups on cell behavior. J. Biomed. Mater. Res. 1990, 24:463-470.
194. Smetana K., Vacik J., Houska M., Souckova D., Lukas J. Macrophage recognition of polymers: effect of carboxylate groups. J. Mater. Sci. Mater. Med. 1993, 4:526-529.
195. Brodbeck W.G., Nakayama Y., Matsuda T., Colton E., Ziats N.P., Anderson J.M. Biomaterial surface chemistry dictates adherent monocyte/macrophage cytokine expression in vitro. Cytokine 2002, 18:311-319.
196. Brodbeck W.G., Patel J., Voskerician G., Christenson E., Shive M.S., Nakayama Y., Matsuda T., Ziats N.P., Anderson J.M. Biomaterial adherent macrophage apoptosis is increased by hydrophilic and anionic substrates in vivo. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:10287-10292.
197. Brodbeck W.G., Macewan M., Colton E., Meyerson H., Anderson J.M. Lymphocytes and the foreign body response: lymphocyte enhancement of macrophage adhesion and fusion. J. Biomed. Mater. Res. A 2005, 74:222-229.
198. Holt D.J., Chamberlain L.M., Grainger D.W. Cell-cell signaling in co-cultures of macrophages and fibroblasts. Biomaterials 2010, 31:9382-9394.
199. Blakney A.K., Swartzlander M.D., Bryant S.J. The effects of substrate stiffness on the in vitro activation of macrophages and in vivo host response to poly(ethylene glycol)-based hydrogels. J. Biomed. Mater. Res. A 2012, 100:1375-1386.
200. Bota P.C., Collie A.M., Puolakkainen P., Vernon R.B., Sage E.H., Ratner B.D., Stayton P.S. Biomaterial topography alters healing in vivo and monocyte/macrophage activation in vitro. J. Biomed. Mater. Res. A 2010, 95:649-657.
201. Juste S., Lessard M., Henley N., Menard M., Halle J.P. Effect of poly-L-lysine coating on macrophage activation by alginate-based microcapsules: assessment using a new in vitro method. J. Biomed. Mater. Res. A 2005, 72:389-398.
202. Strand B.L., Ryan T.L., In't V.P., Kulseng B., Rokstad A.M., Skjak-Brek G., Espevik T. Poly-l-Lysine induces fibrosis on alginate microcapsules via the induction of cytokines. Cell Transplant. 2001, 10:263-275.
203. Otterlei M., Sundan A., Skjak-Braek G., Ryan L., Smidsrod O., Espevik T. Similar mechanisms of action of defined polysaccharides and lipopolysaccharides: characterization of binding and tumor necrosis factor alpha induction. Infect. Immun. 1993, 61:1917-1925.
204. Espevik T., Otterlei M., Skjak-Braek G., Ryan L., Wright S.D., Sundan A. The involvement of CD14 in stimulation of cytokine production by uronic acid polymers. Eur. J. Immunol. 1993, 23:255-261.
205. Berntzen G., Flo T.H., Medvedev A., Kilaas L., Skjak-Braek G., Sundan A., Espevik T. The tumor necrosis factor-inducing potency of lipopolysaccharide and uronic acid polymers is increased when they are covalently linked to particles. Clin. Diagn. Lab. Immunol. 1998, 5:355-361.
206. Flo T.H., Ryan L., Kilaas L., Skjak-Braek G., Ingalls R.R., Sundan A., Golenbock D.T., Espevik T. Involvement of CD14 and beta2-integrins in activating cells with soluble and particulate lipopolysaccharides and mannuronic acid polymers. Infect. Immun. 2000, 68:6770-6776.
207. Park J., Babensee J.E. Differential functional effects of biomaterials on dendritic cell maturation. Acta Biomater. 2012, 8:3606-3617.
208. Shokouhi B., Coban C., Hasirci V., Aydin E., Dhanasingh A., Shi N., Koyama S., Akira S., Zenke M., Sechi A.S. The role of multiple toll-like receptor signalling cascades on interactions between biomedical polymers and dendritic cells. Biomaterials 2010, 31:5759-5771.
209. Rokstad A.M., Donati I., Borgogna M., Oberholzer J., Strand B.L., Espevik T., Skjak-Braek G. Cell-compatible covalently reinforced beads obtained from a chemoenzymatically engineered alginate. Biomaterials 2006, 27:4726-4737.
210. Rokstad A.M., Holtan S., Strand B., Steinkjer B., Ryan L., Kulseng B., Skjak-Braek G., Espevik T. Microencapsulation of cells producing therapeutic proteins: optimizing cell growth and secretion. Cell Transplant. 2002, 11:313-324.
211. Constantinidis I., Rask I., Long R.C., Sambanis A. Effects of alginate composition on the metabolic, secretory, and growth characteristics of entrapped beta TC3 mouse insulinoma cells. Biomaterials 1999, 20:2019-2027.
212. Stabler C., Wilks K., Sambanis A., Constantinidis I. The effects of alginate composition on encapsulated βTC3 cells. Biomaterials 2001, 22:1301-1310.
213. 2-guluronic acid interaction on alginate encapsulated βTC3 cells. Biomaterials 2004, 25:2603-2610.
214. Rokstad A.M., Gustafsson B.I., Espevik T., Bakke I., Pfragner R., Svejda B., Modlin I.M., Kidd M. Microencapsulation of small intestinal neuroendocrine neoplasm cells for tumor model studies. Cancer Sci. 2012, 103:1230-1237.
215. Engler A.J., Sen S., Sweeney H.L., Discher D.E. Matrix elasticity directs stem cell lineage specification. Cell 2006, 126:677-689.
216. Li M., Carpio D.F., Zheng Y., Bruzzo P., Singh V., Ouaaz F., Medzhitov R.M., Beg A.A. An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J. Immunol. 2001, 166:7128-7135.
217. Piccinini A.M., Midwood K.S. DAMPening inflammation by modulating TLR signalling. Mediat. Inflamm. 2010, 1-21. (Article ID 672395).
218. Vasir B., Aiello L.P., Yoon K.H., Quickel R.R., Bonner-Weir S., Weir G.C. Hypoxia induces vascular endothelial growth factor gene and protein expression in cultured rat islet cells. Diabetes 1998, 47:1894-1903.
219. Cowley M.J., Weinberg A., Zammit N.W., Walters S.N., Hawthorne W.J., Loudovaris T., Thomas H., Kay T., Gunton J.E., Alexander S.I., Kaplan W., Chapman J., O'Connell P.J., Grey S.T. Human islets express a marked proinflammatory molecular signature prior to transplantation. Cell Transplant. 2012, 21:2063-2078.
220. Vaithilingam V., Quayum N., Joglekar M.V., Jensen J., Hardikar A.A., Oberholzer J., Guillemin G.J., Tuch B.E. Effect of alginate encapsulation on the cellular transcriptome of human islets. Biomaterials 2011, 32:8416-8425.
221. Ito T., Itakura S., Todorov I., Rawson J., Asari S., Shintaku J., Nair I., Ferreri K., Kandeel F., Mullen Y. Mesenchymal stem cell and islet co-transplantation promotes graft revascularization and function. Transplantation 2010, 89:1438-1445.
222. Davis N.E., Beenken-Rothkopf L.N., Mirsoian A., Kojic N., Kaplan D.L., Barron A.E., Fontaine M.J. Enhanced function of pancreatic islets co-encapsulated with ECM proteins and mesenchymal stromal cells in a silk hydrogel. Biomaterials 2012, 33:6691-6697.
223. Steele J.A.M., Barron A.E., Carmona E., Halle J.P., Neufeld R.J. Encapsulation of protein microfiber networks supporting pancreatic islets. J. Biomed. Mater. Res. A 2012, 100:3384-3391.
224. Cui H., Tucker-Burden C., Cauffiel S.M.D., Barry A.K., Iwakoshi N.N., Weber C.J., Safley S.A. Long-term metabolic control of autoimmune diabetes in spontaneously diabetic nonobese diabetic mice by nonvascularized microencapsulated adult porcine islets. Transplantation 2009, 88:160-169.
225. Johnson A.S., Fisher R.J., Weir G.C., Colton C.K. Oxygen consumption and diffusion in assemblages of respiring spheres: performance enhancement of a bioartificial pancreas. Chem. Eng. Sci. 2009, 64:4470-4487.
226. Johnson A.S., O'Sullivan E., D'Aoust L.N., Omer A., Bonner-Weir S., Fisher R.J., Weir G.C., Colton C.K. Quantitative assessment of islets of Langerhans encapsulated in alginate. Tissue. Eng. 2011, 17:435-449.
227. Madden L.R., Mortisen D.J., Sussman E.M., Dupras S.K., Fugate J.A., Cuy J.L., Hauch K.D., Laflamme M.A., Murry C.E., Ratner B.D. Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:15211-15216.
228. Brauker J., Martinson L.A., Hill R.S., Young S.K., Carr-Brendel V.E., Johnson R.C. Neovascularization of immunoisolation membranes: the effect of membrane architecture and encapsulated tissue. Transplant. Proc. 1992, 24:2924.
229. Brauker J.H., Carr-Brendel V.E., Martinson L.A., Crudele J., Johnston W.D., Johnson R.C. Neovascularization of synthetic membranes directed by membrane microarchitecture. J. Biomed. Mater. Res. 1995, 29:1517-1524.
230. Chiu Y.C., Cheng M.H., Engel H., Kao S.W., Larson J.C., Gupta S., Brey E.M. The role of pore size on vascularization and tissue remodeling in PEG hydrogels. Biomaterials 2011, 32:6045-6051.
231. Bryers J.D., Giachelli C.M., Ratner B.D. Engineering biomaterials to integrate and heal: the biocompatibility paradigm shifts. Biotechnol. Bioeng. 2012, 109:1898-1911.
232. Jackson J.R., Seed M.P., Kircher C.H., Willoughby D.A., Winkler J.D. The codependence of angiogenesis and chronic inflammation. FASEB J. 1997, 11:457-465.
233. Costa C., Incio J., Soares R. Angiogenesis and chronic inflammation: cause or consequence?. Angiogenesis 2007, 10:149-166.
234. West X.Z., Malinin N.L., Merkulova A.A., Tischenko M., Kerr B.A., Borden E.C., Podrez E.A., Salomon R.G., Byzova T.V. Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature 2010, 467:972-976.
235. Fraisl P., Mazzone M., Schmidt T., Carmeliet P. Regulation of angiogenesis by oxygen and metabolism. Dev. Cell 2009, 16:167-179.
236. Clayton H.A., London N.J.M., Colloby P.S., Bell P.R.F., James R.F.L. The effect of capsule composition on the biocompatibility of alginate-poly-l-lysine capsules. J. Microencapsul. 1991, 8:221-233.
237. Vandenbossche G.M., Bracke M.E., Cuvelier C.A., Bortier H.E., Mareel M.M., Remon J.P. Host reaction against empty alginate-polylysine microcapsules. Influence of preparation procedure. J. Pharm. Pharmacol. 1993, 45:115-120.
238. Duvivier-Kali V.F., Omer A., Lopez-Avalos M.D., O'Neill J.J., Weir G.C. Survival of microencapsulated adult pig islets in mice in spite of an antibody response. Am. J. Transplant. 2004, 4:1991-2000.
239. King A., Sandler S., Andersson A. The effect of host factors and capsule composition on the cellular overgrowth on implanted alginate capsules. J. Biomed. Mater. Res. 2001, 57:374-383.
240. Bratlie K.M., Dang T.T., Lyle S., Nahrendorf M., Weissleder R., Langer R., Anderson D.G. Rapid biocompatibility analysis of materials via in vivo fluorescence imaging of mouse models. PLoS One 2010, 5:e10032.
241. Liu W.F., Ma M., Bratlie K.M., Dang T.T., Langer R., Anderson D.G. Real-time in vivo detection of biomaterial-induced reactive oxygen species. Biomaterials 2011, 32:1796-1801.
242. Bakeine G.J., Bertolotti A., Latina M., Congiu T., Prati U., Roveda L., Trotta F., Tormen M., Di Fabrizio E., Carlini G., Facoetti A., Nano R. Surface properties and implantation site affect the capsular fibrotic overgrowth. J. Biomed. Mater. Res. A 2007, 83:965-969.
243. Langlois G., Dusseault J., Bilodeau S., Tam S.K., Magassouba D., Halle J.P. Direct effect of alginate purification on the survival of islets immobilized in alginate-based microcapsules. Acta Biomater. 2009, 5:3433-3440.
244. King A., Strand B., Rokstad A.M., Kulseng B., Andersson A., Skjak-Braek G., Sandler S. Improvement of the biocompatibility of alginate/poly-l-lysine/alginate microcapsules by the use of epimerized alginate as a coating. J. Biomed. Mater. Res. A 2003, 64:533-539.
245. de Vos P., De Haan B., van Schilfgaarde R. Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules. Biomaterials 1997, 18:273-278.
246. Duvivier-Kali V.F., Omer A., Parent R.J., O'Neil J.J., Weir G.C. Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane. Diabetes 2001, 50:1698-1705.
247. Elliott R.B., Escobar L., Tan P.L., Garkavenko O., Calafiore R., Basta P., Vasconcellos A.V., Emerich D.F., Thanos C., Bambra C. Intraperitoneal alginate-encapsulated neonatal porcine islets in a placebo-controlled study with 16 diabetic cynomolgus primates. Transplant. Proc. 2005, 37:3505-3508.
248. King A., Andersson A., Strand B.L., Lau J., Skjak-Braek G., Sandler S. The role of capsule composition and biologic responses in the function of transplanted microencapsulated islets of Langerhans. Transplantation 2003, 76:275-279.
249. Soon-Shiong P., Heintz R.E., Merideth N., Yao Q.X., Yao Z., Zheng T., Murphy M., Moloney M.K., Schmehl M., Harris M., Mendez R., Mendez R., Sandford P.A. Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 1994, 343:950-951.
250. Basta G., Montanucci P., Luca G., Boselli C., Noya G., Barbaro B., Qi M., Kinzer K.P., Oberholzer J., Calafiore R. Long-term metabolic and immunological follow-up of nonimmunosuppressed patients with type 1 diabetes treated with microencapsulated islet allografts: four cases. Diabetes Care 2011, 34:2406-2409.
251. Espevik T., Rokstad A.M., Kulseng B., Strand B., Skjak-Braek G. Mechanims of host immune response to alginate microcapsules. The Bioartificial Pancreas and Other Biohybrid Therapies 2009, 279-290. Transworld Research Network, Kerala. J.P. Halle, P. De Vos, L. Rosenberg (Eds.).